Ces Urol 2023, 27(4):243-250 | DOI: 10.48095/cccu2023032

Consequences of comprehensive oncological treatment on male sexuality

Ta»ána ©rámková
Klinika komplexní onkologické péče, Masarykův onkologický ústav v Brně
Urologická klinika 1. LF a VFN v Praze
Klinika traumatologie LF Masarykovy univerzity v Brně

©rámková T. Consequences of comprehensive oncological treatment on male sexuality. The prevalence and incidence of malignancies in the Czech Republic is increasing. Advances in the diagnosis and treatment modalities applied in the field of oncology during the last decade have led to an increase in the overall survival of patients with many different types of tumors. As a result, maintaining quality of life is another important issue for oncology patients. Sexual problems in oncology patients can stem from impairment of libido, arousal, orgasm and ejaculation, sexual satisfaction and pain. Prostate, bladder and colorectal cancer are the most common malignancies that are diagnosed in middle-aged men who do not renounce their sexuality after undergoing treatment. The consultation with the patient before starting complex treatment should therefore include familiarization with the risk of sexual dysfunctions, treatment modalities and the possibility of penile rehabilitation.

Keywords: Erectile dysfunction, oncological treatment, penile rehabilitation, sexual dysfunction.

Received: July 20, 2023; Accepted: September 26, 2023; Published: December 19, 2023 

PDF will be unlocked 19.12.2023

References

  1. ©rámková T. Muľské stárnutí z pohledu sexuologa. 1. vydání, Praha: Grada­‑Publishing, a. s., 2023; 200 s. ISBN 978-80-271-3525-7.
  2. Weiss P, Zvěřina J. Sexuální chování české populace. Urol praxi. 2009; 10(3): 160-163.
  3. Meisner A, Mamoulakis Ch, Veldink GJ. Sexual problems in patients with cancer. In: Olver N. (ed). The MASCC Textbook of Cancer Supportive Care nad Survivorship. Springer US. 2011; 127-132. Go to original source...
  4. Schover LR. Sexuality. In. Foxhall LE, Rodriguez MA (eds). Advances in Cancer Survivorship Management. New York: Springer. 2015; 401-412. Go to original source...
  5. Chung E, Gillman M. Prostate cancer survivor ship: a review of erectile dysfunction and penile rehabilitation after prostate cancer. Med J Aust. 2014; 200(10): 582-585. Go to original source... Go to PubMed...
  6. Rasmusson E, Gunnlaugsson A, Wieslander E. Erectile dysfunction and absorbed dose to penile base structures in a randomized trial comparing ultrahypofractionated and conventionally fractionated radiation therapy for prostate cancer. Int J Radiat Oncol Biol Phys. 2020; 107(1): 143-151. Go to original source... Go to PubMed...
  7. Bessa A, Martin R, Haggstrom Ch, et al. Unmet needs in sexual health in bladder cancer patients: a systematic review of the evidence. BMC Urology. 2020; 3(20):64. Go to original source... Go to PubMed...
  8. Sterk P, Shekarriz B, Grunter S. Voiding and sexual dysfunction after deep rectal resection and total mesorectal excision. Prospective study of 52 patients. Int J Colorectal, DiS. 2005; 20(5): 423-427. Go to original source... Go to PubMed...
  9. Montorsi F, Brock G, Stolzenburg JU, et al. Effects of tadalafil treatment on erectile function recovery following bilateral nerve­‑sparing radical prostatectomy: a randomised placebo controlled study (REACTT). Eur Urol. 2014; 65(3): 587-596. Go to original source... Go to PubMed...
  10. Salonia A, Bettocchi C, Carvalho J, et al. EAU Guidelines on Sexual and Reproductive Health [online]. Available from: EAU­‑Guidelines­‑on­‑Sexual­‑and­‑Reproductive­‑Health-2023.pdf (d56bochluxqnz.cloudfront.net).
  11. Baccaglini W, Pazeto CL, Correa Barros EA, et al. The role of the low­‑intensity extracorporeal shockwave therapy on penile rehabilitation after radical prostatectomy: a randomized clinical trial. J Sex Med. 2020; 17(4): 688-694. Go to original source... Go to PubMed...
  12. Rosen RC, Riley A, Wagner G, et al. The International Index of Eectile Function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology. 1997; 49(6): 822-830. Go to original source... Go to PubMed...
  13. Mykoniatis I, Pyrgidis N, Sokolakis J, et al. Assessment of combination therapies vs monotherapy for erectile dysfunction: a systematic review and meta­‑analysis. JAMA Netw Open. 2021; 4(2): e2036337. Go to original source... Go to PubMed...
  14. Cui H, Liu B, Song Z, et al. Efficacy and safety of long­‑term tadalafil 5 mg once daily combined with sildenafil 50 mg as needed at the early stage of treatment for patients with erectile dysfunction. Andrologia. 2015; 47(1): 20-24. Go to original source... Go to PubMed...
  15. Anaissie J, Hellstrom WJG. Clinical use of alprostadil topical cream in patiens with erectile dysfunction: a review. Res Rep Urol. 2016; 3(8): 123-131. Go to original source... Go to PubMed...
  16. Chuang FP, Lakin M, Wu ST, et al. Experience with intracavernous injection in the treatment of erectile dysfunction after radical prostatectomy dose considerations. Int J Imp Res. 2011; 23(4): 146-150. Go to original source... Go to PubMed...
  17. Kratochvíl S. Sexuální dysfunkce, 3. vyd. Praha: Grada­‑Publishing, a. s. 2008; 304 s.
  18. Choi E, Buie J, Camacho J, et al. Evolution of androgen deprivation therapy (ADT) and its new emerging modalities in prostate cancer: an update for practicing urologists, clinicians and medical providers. Res Rep Urol. 2022; 14: 87-108. Go to original source... Go to PubMed...
  19. Collins L, Basaria S. Adverse effects of androgen deprivation therapy in men with prostate cancer: a focus on metabolic and cardiovascular complications. Asian J Androl. 2012; 14(2): 222-225. Go to original source... Go to PubMed...
  20. Fryąák Z, Karásek D, Halenka M. Hypogonadismus muľů - příčiny, diagnostika, léčba. Urol praxi. 2010; 11(2): 75-77.
  21. Stárka L. Muľský hypogonadismus a civilizační onemocnění. Čas Lék Čes. 2012; 151(2): 69-72.





Web časopisu Česká urologie je určen pouze pro lékaře a odborníky
z oblasti medicíny nebo farmacie.



Beru na vědomí, ľe informace zveřejněné na těchto stránkách
nejsou určeny pro laickou veřejnost.



Odejít Vstoupit